Sanochemia: Decrease in Sales, Decrease in Losses

Companies › Health Care ♦ Published: January 3, 2011; 19:01 ♦ (Vindobona)

The Vienna Stock Exchange listed manufacturer of pharmaceutical products could improve its results slighty.

Sanochemia: Decrease in Sales, Decrease in Losses / Picture: © Sanochemia Phasmazeutika AG

The financial year 2009/10, which ended by 30 September, reached sales amounting to € 27.1m. In 2009, Sanochemia recorded sales were € 29.5m. Results could not turn into the black zone. However, losses were reduced substantially.

Operating losses decreased from € 4.64m to € 1.26m. EBITDA improved from€ -0.034m to € 2.66m. Costs cutting targets accounting for € 5m…

or Log In

Fast News Search
Related News
Intercell Raises Authorized Capital (December 16, 2010)
Serious setback for Intercell (December 14, 2010)
Economic Chamber in Tokyo: Biotechnology as an Opportunity (December 6, 2010)
Expansion Potential of Austrian Pharmaceutical Industry in Japan (December 1, 2010)
Roche Lays Off 400 Jobs in Styria (November 18, 2010)
Intercell AG: Losses Doubled, Positive Outlook (November 9, 2010)
Unexpected Rise in Research Expenditure (November 4, 2010)
Read More
Sanochemia, Health Policy, Earnings, Pharmaceutical Industry
Featured
Coronavirus Situation at the Vienna International Centre (VIC): Live-Ticker - Five New Positive COVID-19 Cases, Total of 43 Cases
List of National Days of the Home Countries of All Foreign Missions and Delegations in Vienna, Austria
See latest Vindobona Newsletter